Blunted heart rate response during dipyridamole stress SPECT is associated with cardiovascular outcomes in an

Alexander Izhaki1, Aviram Akuka2,3, Alexey Migranov1

  • 1Heart Institute, Edith Wolfson Medical Center, 62 Halochamim Street, Holon, 5810001, Israel.

Insights

Blunted heart rate response (BHRR) during dipyridamole stress cardiac 99mTc-SPECT (DS-SPECT) is linked to increased cardiovascular death. Combining BHRR with abnormal DS-SPECT imaging further elevates risks for cardiovascular morbidity and all-cause mortality.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Diagnostic Imaging

Background:

  • Dipyridamole stress cardiac 99mTc-SPECT (DS-SPECT) is a standard tool for diagnosing myocardial ischemia.
  • Blunted heart rate response (BHRR) during pharmacologic stress is a potential indicator of adverse cardiovascular outcomes.
  • The clinical significance of BHRR in unselected real-world DS-SPECT cohorts remains to be fully elucidated.

Purpose of the Study:

  • To evaluate the prognostic significance of BHRR in patients undergoing DS-SPECT.
  • To compare the predictive value of BHRR with conventional DS-SPECT imaging findings.
  • To assess the combined impact of BHRR and abnormal imaging on cardiovascular outcomes.

Main Methods:

  • A retrospective cohort study included adult patients who underwent DS-SPECT between 2014 and 2017.
  • Clinical data were extracted from electronic medical records and pre-test interviews.
  • Patients were followed up for cardiovascular events and mortality through September 2020.

Main Results:

  • The study included 388 patients; 63.1% exhibited BHRR.
  • BHRR was independently associated with an 8-fold increased risk of cardiovascular death (HR 8.09, p<0.05).
  • Patients with both abnormal DS-SPECT imaging and BHRR had a nearly fourfold increased risk of adverse cardiovascular events (HR 3.79, p<0.05) and the highest all-cause mortality (HR 2.93, p<0.01).

Conclusions:

  • BHRR in patients undergoing DS-SPECT is significantly associated with cardiovascular mortality.
  • The combination of BHRR and abnormal DS-SPECT findings substantially increases the risk of cardiovascular morbidity and all-cause mortality.
  • BHRR should be considered as a valuable prognostic marker in DS-SPECT assessments.
Abstract

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Antianginal Drugs: Nitrates and &#946;-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...